Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.

HARRISON P. and COLBOURNE C., (2022), Molecular Psychiatry

Restricting the spread of SARS-CoV-2 or safeguarding mental health: a false dichotomy?

Taquet M. and Harrison PJ., (2022), Lancet Public Health, 7, e392 - e393

Catechol-O-methyltransferase activity does not influence emotional processing in men

Martens MAG. et al, (2022), Journal of Psychopharmacology, 026988112210890 - 026988112210890

Association between serum lithium level and incidence of COVID-19 infection.

De Picker LJ. et al, (2022), Br J Psychiatry, 1 - 3

Characterizing Affective Variability in Bipolar Disorder and Borderline Personality Disorder, and the Effects of Lithium, Using a Generative Model of Affect

Pulcu E. et al, (2022)

Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues.

Ang G. et al, (2021), Transl Psychiatry, 11

Gabapentin and pregabalin in bipolar disorder, anxiety states, and insomnia: systematic review, meta-analysis, and rationale

CIPRIANI A., (2021), Molecular Psychiatry

Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections

Taquet M. et al, (2021)

Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19

Taquet M. et al, (2021), PLOS Medicine, 18, e1003773 - e1003773

Incidence and outcomes of eating disorders during the COVID-19 pandemic.

HARRISON P. et al, (2021), British Journal of Psychiatry

Neuropsychiatric disorders and COVID-19 - Authors' reply.

Taquet M. et al, (2021), Lancet Psychiatry, 8, 565 - 566

Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes

Colbourne L. et al, (2021), Translational Psychiatry, 11

Cerebral venous thrombosis and portal vein thrombosis: a retrospective cohort study of 537,913 COVID-19 cases

Taquet M. et al, (2021)

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Taquet M. et al, (2021), The Lancet Psychiatry, 8, 416 - 427

Differential follow-up patterns in COVID-19 and comparison cohorts – Authors' reply

Taquet M. et al, (2021), The Lancet Psychiatry, 8, 360 - 361

Induced pluripotent stem cells in psychiatry: an overview and critical perspective

De Los Angeles A. et al, (2021), Biological Psychiatry

Disentangling the complex bidirectional associations between COVID-19 and psychiatric disorder – Authors' reply

Taquet M. et al, (2021), The Lancet Psychiatry, 8, 179 - 179

Six-month Neurological and Psychiatric Outcomes in 236,379 Survivors of COVID-19

Taquet M. et al, (2021)

Incidence of neurodegenerative and cerebrovascular diseases associated with antihypertensive drug classes

Harrison PJ. et al, (2021), The British Journal of Psychiatry, 1 - 3

Incidence of Parkinson’s disease, dementia, cerebrovascular disease and stroke in bipolar disorder compared to other psychiatric disorders: An electronic health records network study of 66 million people

Harrison PJ. and Luciano S., (2020), Bipolar Disorders

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?